Semi-Annual Consolidated Statement Of Income

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7315150

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Semi-annual consolidated statement of income
Statement of income
Net sales
1,105,883,000,000 JPY
1,250,682,000,000 JPY
Cost of sales
406,600,000,000 JPY
472,843,000,000 JPY
Ordinary profit (loss)
442,014,000,000 JPY
525,010,000,000 JPY
Gross profit (loss)
699,283,000,000 JPY
777,838,000,000 JPY
Extraordinary income
14,125,000,000 JPY
1,151,000,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
278,107,000,000 JPY
260,242,000,000 JPY
Extraordinary losses
13,176,000,000 JPY
7,009,000,000 JPY
Profit (loss) before income taxes
442,962,000,000 JPY
519,152,000,000 JPY
Operating profit (loss)
421,176,000,000 JPY
517,596,000,000 JPY
Income taxes - current
115,924,000,000 JPY
160,898,000,000 JPY
Non-operating income
Non-operating income
23,008,000,000 JPY
8,841,000,000 JPY
Income taxes - deferred
2,334,000,000 JPY
-8,473,000,000 JPY
Non-operating expenses
Interest expenses
213,000,000 JPY
185,000,000 JPY
Non-operating expenses
2,171,000,000 JPY
1,428,000,000 JPY
Income taxes
118,258,000,000 JPY
152,425,000,000 JPY
Profit (loss)
324,704,000,000 JPY
324,704,000,000 JPY
324,704,000,000 JPY
324,704,000,000 JPY
366,728,000,000 JPY
366,728,000,000 JPY
366,728,000,000 JPY
366,728,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
13,990,000,000 JPY
1,151,000,000 JPY
Extraordinary losses
Loss on sale of non-current assets
268,000,000 JPY
0 JPY
Impairment losses
JPY
12,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.